logo-loader
viewDirecta Plus PLC

Directa Plus 'captures attention' after years of thorough research, signing NexTech Batteries deal

Directa Plus PLC's (LON:DCTA) Giulio Cesareo talks to Proactive London about the signing of a deal with NexTech Batteries, a Lithium Sulphur batteries firm based in Nevada.

Cesareo explains the 'long journey' which began back in 2013 analysing opportunities in lithium batteries which are now beginning to come to fruition. And in 2017 after analysing their research, they began attracting a lot of attention in this battery domain.

Under the agreement, Directa will supply NexTech with its pristine graphene nanoplatelets, a key raw material for manufacturing the cathode of Lithium Sulphur batteries.

In terms of future opportunities, Cesareo acknowledges the market to be worth '$47m now and moving close to $100m', which he is keen to capitalise on.

Quick facts: Directa Plus PLC

Price: 82 GBX

AIM:DCTA
Market: AIM
Market Cap: £50.16 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Directa Plus PLC named herein, including the promotion by the Company of Directa Plus PLC in any Content on the Site, the Company receives from...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Market Report: FTSE jumps on AstraZeneca COVID-19 vaccine trial and easing...

FTSE 100 rallied in early trading on AstraZeneca’s COVID-19 vaccine trial and the easing of lockdown restrictions from December. London’s blue-chip index rose 20 to 6,371. AstraZeneca PLC (LON:AZN) announced that the coronavirus (COVID-19) vaccine it has developed with Oxford University was...

4 days, 21 hours ago

2 min read